Premier Biomedical Inc
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors… Read more
Market Cap & Net Worth: Premier Biomedical Inc (BIEI)
Premier Biomedical Inc (PINK:BIEI) has a market capitalization of $779.99K ($779.99K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37178 globally and #12100 in its home market, demonstrating a 20.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Premier Biomedical Inc's stock price $0.00 by its total outstanding shares 1299980958 (1.30 Billion).
Premier Biomedical Inc Market Cap History: 2015 to 2025
Premier Biomedical Inc's market capitalization history from 2015 to 2025. Data shows change from $13.32 Billion to $779.99K (-56.24% CAGR).
Premier Biomedical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Premier Biomedical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1404.69x
Premier Biomedical Inc's market cap is 1404.69 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.30 Billion | $39.76K | -$3.76 Million | 32694.88x | N/A |
| 2018 | $79.30 Million | $39.80K | -$399.00K | 1992.68x | N/A |
| 2019 | $519.99K | $14.28K | -$374.00K | 36.41x | N/A |
| 2020 | $1.43 Million | $1.02K | -$403.17K | 1404.69x | N/A |
Competitor Companies of BIEI by Market Capitalization
Companies near Premier Biomedical Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Premier Biomedical Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Premier Biomedical Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Premier Biomedical Inc's market cap moved from $13.32 Billion to $ 779.99K, with a yearly change of -56.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $779.99K | -25.00% |
| 2024 | $1.04 Million | -11.11% |
| 2023 | $1.17 Million | -79.55% |
| 2022 | $5.72 Million | +29.41% |
| 2021 | $4.42 Million | +209.09% |
| 2020 | $1.43 Million | +175.00% |
| 2019 | $519.99K | -99.34% |
| 2018 | $79.30 Million | -93.90% |
| 2017 | $1.30 Billion | -20.00% |
| 2016 | $1.62 Billion | -87.80% |
| 2015 | $13.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Premier Biomedical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $779.99K USD |
| MoneyControl | $779.99K USD |
| MarketWatch | $779.99K USD |
| marketcap.company | $779.99K USD |
| Reuters | $779.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.